Micol Avenali

2.2k total citations
44 papers, 654 citations indexed

About

Micol Avenali is a scholar working on Neurology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Micol Avenali has authored 44 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Neurology, 18 papers in Physiology and 13 papers in Psychiatry and Mental health. Recurrent topics in Micol Avenali's work include Parkinson's Disease Mechanisms and Treatments (22 papers), Lysosomal Storage Disorders Research (13 papers) and Neurological disorders and treatments (7 papers). Micol Avenali is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (22 papers), Lysosomal Storage Disorders Research (13 papers) and Neurological disorders and treatments (7 papers). Micol Avenali collaborates with scholars based in Italy, United Kingdom and United States. Micol Avenali's co-authors include Fabio Blandini, Silvia Cerri, Cristina Tassorelli, Roberto De Icco, Giorgio Sandrini, Cristina Ghezzi, Roberta Zangaglia, Brigida Minafra, Giuseppe Nappi and Claudio Pacchetti and has published in prestigious journals such as Neurology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Micol Avenali

39 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Micol Avenali Italy 16 378 205 132 116 83 44 654
Francesca Magrinelli Italy 14 466 1.2× 164 0.8× 88 0.7× 107 0.9× 30 0.4× 51 784
Milan Zimmermann Germany 17 353 0.9× 159 0.8× 58 0.4× 82 0.7× 42 0.5× 35 546
Hyeo‐Il Ma South Korea 18 545 1.4× 115 0.6× 81 0.6× 106 0.9× 32 0.4× 60 826
Samih Badarny Israel 16 293 0.8× 76 0.4× 53 0.4× 68 0.6× 51 0.6× 37 589
Benjamin Röeben Germany 17 478 1.3× 185 0.9× 95 0.7× 88 0.8× 38 0.5× 37 661
David Bäckström Sweden 10 452 1.2× 165 0.8× 77 0.6× 69 0.6× 31 0.4× 22 589
Stefanie Lerche Germany 19 634 1.7× 279 1.4× 83 0.6× 323 2.8× 106 1.3× 37 1.1k
I. Ziv Israel 16 301 0.8× 162 0.8× 96 0.7× 151 1.3× 28 0.3× 33 777
Jorrit I. Hoff Netherlands 12 426 1.1× 162 0.8× 66 0.5× 39 0.3× 53 0.6× 19 689
Hayat Belaïd France 14 558 1.5× 84 0.4× 106 0.8× 41 0.4× 49 0.6× 31 913

Countries citing papers authored by Micol Avenali

Since Specialization
Citations

This map shows the geographic impact of Micol Avenali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Micol Avenali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Micol Avenali more than expected).

Fields of papers citing papers by Micol Avenali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Micol Avenali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Micol Avenali. The network helps show where Micol Avenali may publish in the future.

Co-authorship network of co-authors of Micol Avenali

This figure shows the co-authorship network connecting the top 25 collaborators of Micol Avenali. A scholar is included among the top collaborators of Micol Avenali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Micol Avenali. Micol Avenali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gervasoni, Jacopo, Carmen Marino, Alberto Imarisio, et al.. (2025). Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson’s disease patients. npj Parkinson s Disease. 11(1). 274–274. 2 indexed citations
2.
Marino, Carmen, Alberto Imarisio, Clara Gasparri, et al.. (2025). 1H-NMR-based metabolomics identifies disrupted betaine metabolism as distinct serum signature of pre-frailty. PubMed. 11(1). 26–26.
3.
Vegezzi, Elisa, Roberta Zangaglia, Ilaria Palmieri, et al.. (2024). Bilateral Dentate Nuclei Hyperintensities and Response to 4-Aminopyridine in a Patient With Childhood-Onset GAA- FGF14 -Related Ataxia. Neurology Genetics. 10(6). e200208–e200208. 2 indexed citations
4.
Chaichoompu, Kridsadakorn, Franco Valzania, Francesco Cavallieri, et al.. (2024). Genetic and Epidemiological Insights into RAB32‐Linked Parkinson's Disease. Movement Disorders. 40(1). 147–151. 2 indexed citations
5.
Imarisio, Alberto, Clara Gasparri, Micol Avenali, et al.. (2024). Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects. Translational Psychiatry. 14(1). 281–281. 7 indexed citations
6.
Avenali, Micol, Silvia Cerri, Ilaria Palmieri, et al.. (2024). Functional Study of SNCA p.V15A Variant: Further Linking α‐Synuclein and Glucocerebrosidase. Movement Disorders. 39(6). 1060–1065.
7.
Avenali, Micol, Francesca Valentino, Federica Ferrari, et al.. (2024). A case report of acute thrombocytopenia induced by Apomorphine in a patient with Parkinson's disease with motor fluctuations. Parkinsonism & Related Disorders. 122. 106911–106911.
8.
Bocci, Tommaso, et al.. (2023). Parkinson disease following COVID‐19: Report of six cases. European Journal of Neurology. 30(5). 1272–1280. 20 indexed citations
9.
Ghezzi, Cristina, Antonio Pisani, Michele Terzaghi, et al.. (2023). Impaired Mitochondrial Respiration in REM‐Sleep Behavior Disorder: A Biomarker of Parkinson's Disease?. Movement Disorders. 39(2). 294–304. 7 indexed citations
10.
Icco, Roberto De, Marta Allena, Micol Avenali, et al.. (2022). Non-Invasive Neuromodulation in the Rehabilitation of Pisa Syndrome in Parkinson's Disease: A Randomized Controlled Trial. Frontiers in Neurology. 13. 849820–849820. 6 indexed citations
11.
Toffoli, Marco, et al.. (2021). The Remote Assessment of Parkinsonism Supporting the Ongoing Development of Interventions in Gaucher Disease. Neurodegenerative Disease Management. 11(6). 451–458. 6 indexed citations
12.
Avenali, Micol, Daniele Martinelli, Massimiliano Todisco, et al.. (2021). Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation. Frontiers in Neurology. 12. 643713–643713. 9 indexed citations
13.
Avenali, Micol, Fabio Blandini, & Silvia Cerri. (2020). Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease. Frontiers in Aging Neuroscience. 12. 97–97. 64 indexed citations
14.
Cosentino, Giuseppe, Cristina Tassorelli, Paolo Prunetti, et al.. (2020). Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes. Clinical Neurophysiology. 131(9). 2200–2208. 10 indexed citations
15.
Icco, Roberto De, Micol Avenali, Silvano Cristina, et al.. (2019). Body Weight Support Combined With Treadmill in the Rehabilitation of Parkinsonian Gait: A Review of Literature and New Data From a Controlled Study. Frontiers in Neurology. 9. 1066–1066. 16 indexed citations
16.
Avenali, Micol, Roberto De Icco, Michèle Tinazzi, et al.. (2018). Pain in focal dystonias – A focused review to address an important component of the disease. Parkinsonism & Related Disorders. 54. 17–24. 32 indexed citations
17.
Bottiroli, Sara, Marta Allena, Grazia Sances, et al.. (2017). Changes in anxiety and depression symptoms associated to the outcome of MOH: A post-hoc analysis of the Comoestas Project. Cephalalgia. 38(4). 646–654. 19 indexed citations
18.
Tassorelli, Cristina, Grazia Sances, Micol Avenali, et al.. (2017). Botulinum toxin for chronic migraine: Clinical trials and technical aspects. Toxicon. 147. 111–115. 9 indexed citations
19.
Sances, Grazia, Roberto De Icco, Micol Avenali, et al.. (2015). Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy. The Journal of Headache and Pain. 16(1). 532–532. 31 indexed citations
20.
Tassorelli, Cristina, Roberto De Icco, Enrico Alfonsi, et al.. (2014). Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: A placebo controlled study. Parkinsonism & Related Disorders. 20(11). 1140–1144. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Magrinelli Breakdown of academic impact, for papers by Milan Zimmermann Breakdown of academic impact, for papers by Hyeo‐Il Ma Breakdown of academic impact, for papers by Samih Badarny Breakdown of academic impact, for papers by Benjamin Röeben Breakdown of academic impact, for papers by David Bäckström Breakdown of academic impact, for papers by Stefanie Lerche Breakdown of academic impact, for papers by I. Ziv Breakdown of academic impact, for papers by Jorrit I. Hoff Breakdown of academic impact, for papers by Hayat Belaïd
Rankless by CCL
2026